)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Faron Pharmaceuticals
Faron Pharmaceuticals (FARON) investor relations material
Faron Pharmaceuticals H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary4 Mar, 2026
Executive summary
Achieved leading position in high-risk MDS treatment with outstanding clinical results, including deep and durable complete remissions, transfusion independence, and positive Phase I/II results, with orphan drug designations from EMA and FDA.
Presented strong efficacy and survival data at major congresses, reinforcing bexmarilimab's potential in HR-MDS.
Advanced BEXMAB program with successful completion of phase I/II enrollment and expanded research into solid tumors with multiple investigator-initiated trials planned.
Strengthened management and board with new CFO and experienced industry leaders.
Improved financial position through €12M private placement and €35M convertible bond arrangement, repaying previous secured loans.
Financial highlights
Year-end cash position of €12.3 million, up from €9.5 million in 2024, driven by private placement and convertible bond arrangements.
Reported annual loss of €27.3 million and net assets of minus €18.5 million.
114.4 million shares outstanding at year-end 2025, increasing to 119.5 million by March 2026.
Loss per share improved to €0.24 from €0.29 year-over-year.
R&D expenses increased to €12.7M from €11.7M, reflecting expanded clinical activities.
Outlook and guidance
Planning a €40 million rights offering to fund phase 2b randomized trial and advance lead asset to key milestones.
Directors estimate current cash will support activities until Q2 2026; additional financing is being pursued.
Anticipated first patient enrollment in solid tumor and high-risk MDS phase II trials in 2026.
Investigator-initiated trials in multiple cancer indications expected to generate additional data.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Faron Pharmaceuticals earnings date
H1 202626 Aug, 2026
Faron Pharmaceuticals
Next Faron Pharmaceuticals earnings date
H1 202626 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Faron Pharmaceuticals is a Finland-based clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer and other serious conditions. The company’s research targets immune system modulation to treat aggressive diseases with unmet medical needs. Faron Pharmaceuticals is headquartered in Turku, Finland, and its shares are listed on the AIM.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage